Evidence for a Nucleotide Receptor on Adrenal Medullary Endothelial Cells Linked to Phospholipase C and Phospholipase D
Overview
Authors
Affiliations
1. We have investigated whether the 'atypical' P2-purinoceptor previously described on adrenal microvasculature endothelial cells is a nucleotide receptor (responds to pyrimidines and purines) and is linked to phospholipase D as well as phospholipase C. 2. Cultured bovine adrenal medullary endothelial (BAME) cells responded to the pyrimidine UTP, as well as the purines. The total [3H]-inositol phosphate responses were with a rank order of UTP > ATP- = adenosine 5'-O-(3-thio-triphosphate) (ATP gamma S) >> 2MeSATP. The selective P2x agonist beta, gamma-methylene ATP was inactive. 3. Construction of dose-response curves to ATP, ATP gamma S and UTP in the presence and absence of additional agonists showed that responses to ATP gamma S and UTP were not additive, nor were those to UTP and ATP. This suggests that purines and pyrmidines acted via a common nucleotide receptor. 4. 32P-labelled BAME cells, in the presence of butanol, produced [32P]-phosphatidylbutanol (PBut) when stimulated with ATP gamma S or the protein kinase C activator, tetradecanoyl phorbol acetate (TPA). 5. Cells labelled with [3H]-palmitate and stimulated in the presence of butanol generated [3H]-PBut with the same order of agonist potencies seen for inositol phosphate responses. 6. The protein kinase C inhibitor, Ro 31-8220, abolished TPA and agonist stimulation of [3H]-PBut production. 7. These observations, and our related studies on bovine aortic endothelial cells, provide the first demonstration of a phospholipase C linked nucleotide receptor on vascular endothelial cells. It is concluded that BAME cells express a nucleotide receptor linked to phospholipase C and phospholipase D, but that activation of phospholipase D is probably down-stream of phospholipase C.
P2Y receptor-mediated Ca2+ signalling in cultured rat aortic smooth muscle cells.
Pediani J, McGrath J, Wilson S Br J Pharmacol. 1999; 126(7):1660-6.
PMID: 10323600 PMC: 1565940. DOI: 10.1038/sj.bjp.0702470.
P2 receptor subtypes in the cardiovascular system.
Kunapuli S, Daniel J Biochem J. 1998; 336 ( Pt 3):513-23.
PMID: 9841859 PMC: 1219898. DOI: 10.1042/bj3360513.
Webb T, Feolde E, VIGNE P, Neary J, Runberg A, Frelin C Br J Pharmacol. 1996; 119(7):1385-92.
PMID: 8968547 PMC: 1915814. DOI: 10.1111/j.1476-5381.1996.tb16050.x.
Mateo J, Miras-Portugal M, Castro E Br J Pharmacol. 1996; 119(6):1223-32.
PMID: 8937727 PMC: 1915897. DOI: 10.1111/j.1476-5381.1996.tb16026.x.
Graham A, McLees A, Kennedy C, Gould G, Plevin R Br J Pharmacol. 1996; 117(6):1341-7.
PMID: 8882634 PMC: 1909785. DOI: 10.1111/j.1476-5381.1996.tb16734.x.